EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis

Robert Bissonnette, Andreas Pinter, Laura K Ferris, Sascha Gerdes, Phoebe Rich, Ronald Vender, Megan Miller, Yaung-Kaung Shen, Arun Kannan, Shu Li, Cynthia DeKlotz, Kim Papp iD

New England Journal of Medicine · 08.02.2024 · 390 (6) · 510-521

DOI: 10.1056/nejmoa2308713 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 08.02.2024. Verfasst von Robert Bissonnette und 11 weiteren Autor:innen. Beteiligte Einrichtung: From Innovaderm Research, Montreal (R.B.), McMaster University and Dermatrials Research, Hamilton, ON (R.V.), Alliance Clinical Trials and Probity Me…. Hauptthemen laut MEDLINE: Psoriasis, Receptors, Interleukin, Antibodies, Monoclonal. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Janssen Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisReceptors, InterleukinAntibodies, MonoclonalHumansDouble-Blind MethodInterleukin-23PeptidesSeverity of Illness IndexTreatment OutcomeAdministration, OralDose-Response Relationship, Drug

Substanzen

Interleukin-23PeptidesIL23R protein, humanReceptors, InterleukinAntibodies, Monoclonal

Autor:innen und Institutionen

  • From Innovaderm Research, Montreal (R.B.), McMaster University and Dermatrials Research, Hamilton, ON (R.V.), Alliance Clinical Trials and Probity Medical Research, Waterloo, ON (K.P.), and the Division of Dermatology,…

ORCID-Profile: Kim Papp

Förderung

  • Janssen Research and Development

Zitieren

APA

Bissonnette, R., Pinter, A., Ferris, L. K., Gerdes, S., Rich, P., Vender, R., Miller, M., Shen, Y. K., Kannan, A., Li, S., DeKlotz, C., & Papp, K. (2024). An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis. New England Journal of Medicine, 390(6), 510-521. https://doi.org/10.1056/nejmoa2308713

Vancouver

Bissonnette R, Pinter A, Ferris LK, Gerdes S, Rich P, Vender R, et al. An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis. New England Journal of Medicine. 2024;390(6):510-521. doi:10.1056/nejmoa2308713

BibTeX
@article{Bissonnette2024,
  author = {Bissonnette, Robert and Pinter, Andreas and Ferris, Laura K and Gerdes, Sascha and Rich, Phoebe and Vender, Ronald and Miller, Megan and Shen, Yaung-Kaung and Kannan, Arun and Li, Shu and DeKlotz, Cynthia and Papp, Kim},
  title = {An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {6},
  pages = {510--521},
  doi = {10.1056/nejmoa2308713}
}
Kostenlos starten →